C/EBPα aggravates renal fibrosis in CKD through the NOX4-ROS-apoptosis pathway in tubular epithelial cells

• Published in: Biochimica et biophysica acta. Molecular basis of disease 2024-03, Vol.1870 (3), p.167039-167039, Article 167039
• Main Authors: Xia, Ziru, Wei, Zhaonan, Li, Xin, Liu, Yunzi, Gu, Xiangchen, Huang, Siyi, Zhang, Xiaoyue, Wang, Weiming
• Format: Article
• Language: English
• Subjects: Apoptosis; C/EBPα; Chronic kidney disease; l-Theanine; NOX4
• ISSN: 0925-4439; 1879-260X
• DOI: 10.1016/j.bbadis.2024.167039

Chronic kidney disease (CKD) is a prevalent renal disorder with various risk factors. Emerging evidence indicates that the transcriptional factor CCAAT/enhancer binding protein alpha (C/EBPα) may be associated with renal fibrosis. However, the precise role of C/EBPα in CKD progression remains unexplored. We investigated the involvement of C/EBPα in CKD using two distinct mouse models induced by folic acid (FA) and unilateral ureteral obstruction (UUO). Additionally, we used RNA sequencing and KEGG analysis to identify potential downstream pathways governed by C/EBPα. Cebpa knockout significantly shielded mice from renal fibrosis and reduced reactive oxygen species (ROS) levels in both the FA and UUO models. Primary tubular epithelial cells (PTECs) lacking Cebpa exhibited reduced apoptosis and ROS accumulation following treatment with TGF-β. RNA sequencing analysis suggested that apoptosis is among the primary pathways regulated by C/EBPα, and identified NADPH oxidoreductase 4 (NOX4) as a key protein upregulated upon C/EBPα induction (ICCB280). Treatment with l-Theanine, a potential NOX4 inhibitor, mitigated renal fibrosis and inflammation in both the FA and UUO mouse models. Our study unveils a role for C/EBPα in suppressing renal fibrosis, mitigating ROS accumulation, and reducing cell apoptosis. Furthermore, we investigate whether these protective effects are mediated by C/EBPα's regulation of NOX4 expression. These findings present a promising therapeutic target for modulating ROS and apoptosis in renal tubular cells, potentially offering an approach to treating CKD and other fibrotic diseases. [Display omitted] •Cebpa knockout diminishes renal fibrosis and ROS in FAN and UUO models.•C/EBPα regulates NOX4-apoptosis pathway.•l-Theanine, a potential NOX4 inhibitor, mitigxates renal fibrosis and inflammation.